Get Ready to Brighten Up Your Investment Portfolio: Therma-Bright’s LIFE Financing and Private Placement Raise Up to CAD6 Million!

LIFE Financing and Concurrent Private Placement to Include Common Shares Only and no Warrants Toronto, Ontario–(Newsfile Corp. – September 27, 2024) – Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma Bright” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce…

Read More

Is Ubisoft’s Pricing Too Aggressive? A Heartfelt Look at the Outlaws and AC: Shadows Launch Revision

Ubisoft’s Stock Facing Challenges Weak Game Launches and Damaged Goodwill Ubisoft, one of the leading game developers in the industry, is currently facing challenges that are impacting its stock value. The company’s recent game launches have not been well-received by players and critics alike, leading to a decrease in goodwill towards the brand. This has…

Read More

UBS Group AG Notifies Participation: A Significant Update for Investors

UBS Group AG Discloses Transparency Notification to Solvay Brussels, September 27, 2024, 08:30 CEST – Regulated Information In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%. The notification, dated September 24, 2024, contains the…

Read More

Breaking News: Cue Biopharma Sets Record with $12.0 Million Public Offering

Cue Biopharma Announces Public Offering of Common Stock September 26, 2024 Boston, MA Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company specializing in therapeutic biologics, has announced the pricing of an underwritten public offering of common stock. The offering includes 11,564,401 shares of common stock and accompanying common stock warrants, as well as pre-funded…

Read More

Get Ready to Invest: Theriva Biologics Drops the Mic with $2.5 Million Public Offering!

Theriva Biologics, Inc. Announces Pricing of Public Offering What’s the Buzz? Hey there, fellow financial enthusiasts! Have you heard the news about Theriva Biologics, Inc.’s recent announcement regarding its public offering? If not, let me fill you in on the deets. The diversified clinical-stage company is making waves in the biotech world with its development…

Read More